期刊文献+

腹腔镜肾肿瘤根治切除术围手术期外周血Fas/FasL的表达及意义

The expression and significance of Fas and FasL on peripheral blood cell of patients with renal cell carcinoma undergone either laparoscopic radical nephrectomy or open radical nephrectomy
暂未订购
导出
摘要 目的探讨腹腔镜肾癌根治术前后患者外周血Fas/FasL表达及意义。方法对限期行肾肿瘤的患者均衡分成两组,腹腔镜组(LN)和开放手术组(ON)共52例。手术前、术后1 d、3 d、5 d,Fas/FasL免疫指标的变化进行检测,并对改变程度进行比较。结果两组手术均获成功,两组术中术后无明显并发症。两组术中失血、用止痛剂与手术后住院天数存在显著差异。FasL(LN组与ON组)均高于正常参考值,Fas(术后5 d)、FasL(术后1 d、5 d)、腹腔镜组与开放手术组间存在统计学差异(以α=0.05为检验水准)。结论外周血Fas/FasL表达与肿瘤发生发展、创伤程度有关,腹腔镜肾癌根治术低表达,开放手术高表达,腹腔镜肾癌根治术对机体免疫影响小;肿瘤患者均处于高表达,手术后表达下降,说明机体免疫功能得到恢复。 Objective The expression and significance of Fas and FasL on peripheral blood cell of patients with renal cell carcinoma (RCC) undergone either laparoscopic radical nephrectomy or open radical nephrectomy. Methods 52 patients with renal cell carcinoma admitted to Changzheng Hospital were balanced and allocated randomly into two groups. Cellular immune function and changes were studied in groups of patients undergoing either laparoscopic radical nephrectomy (LN) or open radical nephrectomy (ON). Fas/FasL were measured by using flow cytometry. The tests being peri-operation and 1 d,3 d,5 d after operations The statistical methods were repeated-measured ANOVA T test and χ^2 test. If P〈 0.05, the difference is significant. Results Operations in both groups were successful with no obvious complications. Those in LN group, the number of patients using pain-killer, hospital stay and blood loss were less considerably than ON group. After operations Fas/FasL had significant changes in both groups (P〈0.05). Conclusion The aberration of Fas/FasL is related with thedegree of trauma, occurrence and development of renal cell carcinoma. Comparing with normal datum, the expression of Fasl in RCC; is high. The expression of Fas/FasL in RCC; of ON group is much higher than that of LN group after-s. The immune response is less pronounced after a laparoscopic procedure as compared to a conventional approach in patients with renal cell carcinoma.
出处 《同济大学学报(医学版)》 CAS 2007年第6期38-40,48,共4页 Journal of Tongji University(Medical Science)
关键词 手术治疗 肾肿瘤 FAS/FASL surgical treatment renal cell carcinoma Fas/FasL
  • 相关文献

参考文献4

  • 1Landman J, Olweny E, Sundaram CP, et al. Prospective comparison of the immunological and stress response following laparoscopic and open surgery for localized renal cell carcinoma[J]. J Urol, 2004, 171(4) : 1456 - 1460.
  • 2桑威,徐开林(审校),潘秀英(审校).Fas/FasL系统参与的几种生物学效应[J].国际免疫学杂志,2006,29(6):389-392. 被引量:20
  • 3Choi C, Benveniste EN. Fas ligand /Fas system in the brain: regulator of immune and apoptotic responses[J]. Brain Res Brain Res Rev, 2004,44 (1) : 65 - 81.
  • 4吴国英,靳风烁,李黔生,江军,李彦峰.Fas、FasL在肾癌组织中的表达及其意义[J].第三军医大学学报,2004,26(16):1488-1490. 被引量:4

二级参考文献26

  • 1Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas(CD95), Fas ligand, Bcl-2, and Bax[J].Immunol, 1998, 160(4): 1627-1637.
  • 2Nagta S, Golstein P. The Fas death factor[J]. Science, 1995, 267(5203): 1449 - 1456.
  • 3Griffith T S, Brunner T, Fletcher S M, et.al. Fas ligand induced apopotosis as a mechanism of immune privilege [J]. Science, 1995, 270(17):1189- 1192.
  • 4Kase S, Osaki M, Adachi H, et al. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas[J]. Int J Oncol, 2002, 20(2):291 - 297.
  • 5Shinoura N, Ohashi M, Yoshida Y, et al. Adenoviras-mediated overexpression of Fas induces apoptosis of gliomas[J]. Cancer Gene Ther, 2000,7(2): 224 - 232.
  • 6Grobholz R, Zentgraf H, Kohrmann K U, et al. Bax, Bcl-2, Fas and FasL antigen expression in human seminoma: correlation with the apoptotic index[J]. APMIS, 2002, 110(10): 724 - 732.
  • 7Mullauer L, Mosberger I, Grusch M, et al. Fas ligand is expressed in normai breast epithelial cells and is frequently up-regulated in breast cancer[J]. J Pathol, 2000, 190(1): 20-30.
  • 8Mojtahedzadeh S, Hashimoto S, Nakashima Y, et al. Clinicopathologic relevance of apoptotic and proliferative factors in human lung adenocarcinoma: Fas expression correlates with the histologic subtype, but not with the degree of apoptesis[J]. Pathol Res P
  • 9Bohana-Kashtan O,Civin Cl.Fas ligand as a tool for immunosuppression and generation of immune tolerance.Stem Cells,2004,22 (6):908-924.
  • 10Orlinick JR,Vaishnaw AK,Elkon KB.Structure and function of Fas/Fas ligand.Int Rev Immunol,1999,18 (4):293-308.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部